Quantcast

Latest squamous cell carcinoma Stories

2011-03-02 16:46:43

Melatonin is known to have cancer-protective properties, and shift work can induce desynchrony of the circadian system, reducing melatonin production. Shift work has been thought to have important health impacts, with evidence linking shift work to an increased risk of several cancers including breast, endometrial, prostate, and colorectal, and non-Hodgkin lymphoma.  In a recent study, researchers at Brigham and Women's Hospital (BWH) found that shift work may be associated with a...

2011-02-27 00:01:40

Tans are caused by harmful ultraviolet (UV) radiation from the sun or tanning lamps, and if you've had one, you've sustained skin cell damage. Middleburg, VA (PRWEB) February 25, 2011 With Spring Break approaching, The Less Cancer Campaign wishes to remind sun worshippers of some of the dangers of tanning. The Skin Cancer Foundation tells us that a tan, whether you get it on the beach, in a bed, or through incidental exposure, is bad news any way you acquire it. Tans are caused by harmful...

2011-02-25 13:11:30

Phase III results At the 3rd International Conference on innovative approaches in Head and Neck Oncology (ICHNO), Dr Hanna Rahbek Mortensen and colleagues at hospitals and institutes in Denmark presented results from a large prospective trial, the DAHANCA 6 & 7 study. The study, conducted across the country, investigated risk factors for developing dysphagia (swallowing dysfunction), after undergoing radiotherapy treatment for a head & neck cancer. "We followed 1,476 patients with...

2011-02-24 21:11:23

Validation of a gene expression signature for distinguishing metastasizing from non-metastasizing tumors in head and neck cancers, on a large multi-center cohort The validation of a test, based on gene expression and predicting the tumours that will metastasize in lymph nodes of head & neck cancers, was presented today at the 3rd International Conference on innovative approaches in Head and Neck Oncology (ICHNO), in Barcelona. Dr Robert Takes, from the Radboud University Nijmegen Medical...

2011-02-23 00:30:00

SEATTLE, Feb. 23, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that updated phase II study results of OPAXIO (paclitaxel poliglumex) in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the February 3, 2011 issue of the American Journal of Clinical Oncology, Dipetrillo, et al., which demonstrate that 38% (15/40) of the patients receiving OPAXIO in combination with cisplatin and...

2011-02-22 02:50:48

Sharing printed educational materials about the risk of squamous cell carcinoma with kidney transplant recipients appeared to be effective at increasing skin self-examination and encouraging follow-up with a dermatologist to determine risk of cancer, according to a report posted online today that will appear in the June issue of Archives of Dermatology, one of the JAMA/Archives journals. "In the United States, an estimated 100,000 living kidney transplant recipients are at risk to develop...

2011-02-17 12:36:00

BOCA RATON, Fla., Feb. 17, 2011 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 9th Annual South Beach Symposium(TM) in Miami Beach, FL on February 17-21, 2011. The South Beach Symposium(TM) is a comprehensive session with three non-overlapping tracks in clinical dermatology, aesthetics, and practice management. Sensus Healthcare is featuring superficial radiotherapy (SRT) with their SRT-100(TM) advanced platform as a complimentary tool for the...

2011-02-17 11:55:00

BOCA RATON, Fla., Feb. 17, 2011 /PRNewswire/ -- Sensus Healthcare has announced the formation of a Medical Advisory Board (MAB). Accepting to Chair this Board as Medical Director is Dr. Armand B. Cognetta, distinguished Dermatologist and founder of Dermatology Associates of Tallahassee, Florida. Dr. Cognetta is recognized as a leader and innovator in his field. Dr. Cognetta will provide clinical guidance and patient advocacy in the ongoing development of the Company's leading Superficial...

2011-02-16 16:16:52

Smokers who continue to smoke while undergoing radiation treatments for head and neck cancer fare significantly worse than those who quit smoking before therapy, according to a study in the February issue of the International Journal of Radiation Oncology"¢Biology"¢Physics, an official journal of the American Society for Radiation Oncology (ASTRO). Although the association between tobacco smoking and head and neck cancers has long been established, there had been little data...

2011-02-04 13:17:00

BOCA RATON, Fla., Feb. 4, 2011 /PRNewswire/ -- EpiCareSRT(TM) (www.epicaresrt.com) announced today it has entered into a strategic partnership with Sensus Healthcare(TM) (www.sensushealthcare.com) to take new aim at skin cancer by providing the first mobile service to bring low-dose superficial radiation therapy directly to the point-of-care in dermatology offices. (Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO ) EpiCareSRT's mobile services application of the Sensus...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related